Home | Add Company | Subscribe | Search | Contact

BioPharmaLink

 

Login

Directory:

Add Company

Your company can benefit from enhanced listings. Questions? Read our FAQ first.

 

Personalized notification service and newsletter info

Subscribe (free) to get notified of new additions.

 

Learn more About us and about our Services

 

Contact us

Lisinopril

New registered available EU registration dossier for licensing

Offer available for: licensing

Pharmaceutical form and dosage: 2,5-5-10-20 mg Tablets


Type:

- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)


Therapeutic target:

- Cardiovascular

Action: Antihypertensives

Company Contact


Corporate data: PharmaRegistrations
Belgium

Contact for this offer: Lieve Vermassen

Or check this company's:


Full Description:
Lisinopril dossier:
-New readily available for licensing
-Marketing Authorization obtained in Denmark (we can also register in other countries)
-Stability: 25C: 30 months + continued, 40C: 6 months


Availability and Market information:

Status: Registered (MA obtained)

Market(s) and Registration Info: (date: concerns Marketing Authorization)
- Denmark
- Netherlands
- Belgium
Registration info: On-going in The Netherlands and Belgium
On request: registration in other countries
BE available


Market information

Other Market Info:


Patent Information:
Name: Zestril
Patent expiration date: 2002
Patent info: Development of pharmaceuticals which are still under patent is carried out according to EU-requirements in countries with no existing patents or with Bolar-provisions.
We deliver to all countries where the substance and its use are not protected by patents.


Suggestion box | Disclaimer | Privacy Policy | Rules & Regulations
Copyright© Cofidei, Inc. Last modified: 31-Oct-2001.

Home | Add Company | Subscribe to Newsletter | Search Companies | Search Offers | Power search